CONNECT WITH US
Funding Tracker

Funding Tracker

Even Healthcare raises $50 Mn in Series B led by Khosla Ventures

Entrackr logo

Published on

Add as a preferred source on Google
Even Healthcare raises $50 Mn in Series B led by Khosla Ventures

Even Healthcare, an integrated managed care company, has raised $50 million in a Series B funding round led by existing investor Khosla Ventures, with participation from Alpha Wave. The round triples its valuation from the previous raise 18 months ago and takes its total funding to over $120 million.

In August 2026, Entrackr had  exclusively reported that the company was set to raise Rs 208 crore, or $22 million, in a Series B round led by Khosla Ventures, with participation from DLB Ventures, Simon Fiduciaria and others. In January 2026, Even Healthcare raised $20 million in a round led by Lachy Groom and Alpha Wave.

The latest fundraise comes after the company laid off around 350 employees in August 2026, as reported exclusively by Entrackr.

The proceeds from the latest round will be used to launch five new hospitals across Bengaluru over the next six months, the company said in a press release.

Co-founded in 2021 by Mayank Banerjee, Matilde Giglio and Alessandro Ialongo, Even Healthcare operates a membership-based healthcare model that offers primary care, diagnostics and hospital services. Unlike traditional hospital chains, the company focuses on continuity of care and patient recovery, with care teams managing patients across consultations, diagnostics, hospitalisation and post-discharge recovery.

Even Healthcare is yet to file its FY26 financials with the Registrar of Companies (RoC). 24 crore in FY24. 40 crore during the same period.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.